Inosine Pranobex Overview Categories 6 Anti-infective drugs6.5 Antivirals, systemic6.5.1 Herpes and cytomegalovirus infection Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Manufacturers of Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage 's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 1 g1 (1)8 hourlyPOFor 7 to 14 days for mucocutaneous herpes simplex.1 g1 (1)8 hourlyPOFor 14 to 28 days as an an adjunct to standard topical treatment for genital warts.50 to 100 mg/kg75 (75)4 hourlyPOIn divided doses for subacute scherosing panencephalitis. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Inosine Pranobex in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Inosine Pranobex Overview Categories 6 Anti-infective drugs6.5 Antivirals, systemic6.5.1 Herpes and cytomegalovirus infection Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Manufacturers of Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage 's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 1 g1 (1)8 hourlyPOFor 7 to 14 days for mucocutaneous herpes simplex.1 g1 (1)8 hourlyPOFor 14 to 28 days as an an adjunct to standard topical treatment for genital warts.50 to 100 mg/kg75 (75)4 hourlyPOIn divided doses for subacute scherosing panencephalitis. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Inosine Pranobex in Pakistan Back to top Previous Drug Generic - Next Drug Generic